Tirzepatide research reference

Tirzepatide is a dual GIP and GLP-1 receptor agonist and is also the active ingredient in FDA-approved prescription products. That does not make a separately sold research material an approved finished drug.

Dual-receptor terminology

Tirzepatide is commonly described as a dual GIP and GLP-1 receptor agonist. Research may focus on receptor pharmacology, analytical characterization, peptide chemistry and comparative multi-agonist programs.

Research material versus approved medicine

FDA approval applies to specific finished drug products, manufacturers, formulations and labeling. A research-use material is not the approved finished drug and must not be represented as therapeutically equivalent or intended for personal use.

Documentation focus

Driftless Research will separate compound identity, lot documentation and research-use labeling from any clinical or consumer claims.